American Trust’s Bristol-Myers Squibb BMY Stock Holding History

American Trust’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-5,713	Closed	-$346K	–	336
2026 Q1	$346K	Buy	+5,713	New	+$333K	0.03%	203
2023 Q3	–	Sell	-7,337	Closed	-$469K	–	298
2023 Q2	$469K	Sell	7,337 -251	-3%	-$16.8K	0.03%	229
2023 Q1	$526K	Buy	7,588 +35	+0.5%	+$2.47K	0.04%	203
2022 Q4	$543K	Sell	7,553 -126	-2%	-$9.5K	0.05%	201
2022 Q3	$546K	Sell	7,679 -230	-3%	-$16.7K	0.05%	181
2022 Q2	$609K	Buy	7,909 +2,880	+57%	+$219K	0.05%	188
2022 Q1	$368K	Buy	+5,029	New	+$338K	0.02%	305

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

American Trust's BMY Position: Q2 2026 in Review

American Trust sold out of Bristol-Myers Squibb (BMY) in Q2 2026, closing a stake of 5,713 shares — an estimated $346K sold.

American Trust first reported a position in BMY in Q1 2022 and held it in 7 quarters. The position peaked at $609K in Q2 2022. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

American Trust reported no remaining Bristol-Myers Squibb position as of Q2 2026 after selling out during the quarter.
American Trust sold 5,713 Bristol-Myers Squibb shares in Q2 2026, an estimated $346K.
American Trust first reported a position in Bristol-Myers Squibb in Q1 2022 and held it in 7 quarters.
American Trust's Bristol-Myers Squibb position peaked at $609K in Q2 2022.
2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on American Trust's 13F filing for Q2 2026, filed 14 Aug 2026.